The latest update is out from Pfizer (PFE).
Pfizer Inc. is on the hunt for a new Chief Scientific Officer to take over from Dr. Mikael Dolsten, who’s been with the company for over 15 years. The search will extend beyond the company as they look for a successor, while Dr. Dolsten will stay on board to ensure a smooth transition until at least the end of February 2025.
Find detailed analytics on PFE stock on TipRanks’ Stock Analysis page.
